Moderna | MRNA - Des Atouts

Prix De L'Action
54.57
Variation Quotidienne
0.85 1.58%
Mensuellement
6.42%
Annuel
117.15%
Q2 Prévisions
52.54




Des Atouts Changement Date
Acadia Pharmaceuticals USD 1.56B 233.42M 2025-12
Agios Pharmaceuticals USD 1.3B 88.48M 2025-12
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Amgen USD 90.59B 445M 2025-12
Arrowhead Research USD 1.6B 218.89M 2025-12
Biogen USD 29.44B 232M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Celltrion KRW 21.08T 530.63B 2025-09
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Dianthus Therapeutics USD 530.92M 46.52M 2025-12
Divis Laboratories Ltd INR 181.51B 12.19B 2025-09
Esperion Therapeutics USD 465.89M 101.87M 2025-12
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
Incyte USD 6.96B 627.62M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
Kangmei Pharma CNY 13.68B 38.19M 2025-09
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Moderna USD 12.34B 203M 2025-12
Organigram Holdings CAD 530.67M 31.54M 2025-12
Ovoca Bio EUR 1.66M 9.75M 2025-06
Pharma Mar EUR 395.08M 53.42M 2025-12
Puma Biotechnology USD 202.86M 7.95M 2025-09
Qiagen NV USD 6.3B 257.54M 2025-12
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
Sartorius EUR 9.61B 413.4M 2025-09
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Tilray USD 2.1B 15.95M 2025-09
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
United Therapeutics USD 7.88B 528.9M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12
Zealand Pharma A/S 15.95B 848.45M 2025-12
Zz Pientze Pharmaceu CNY 17.48B 1.23B 2025-09